Table 3 Suggestive plasma ApoH GWAS results for the discovery meta-analysis and the replication sample for Model 2 (age, sex, assay batch effects, hypolipidemic medication).

From: Genome-wide significant results identified for plasma apolipoprotein H levels in middle-aged and older adults

SNP (rs)

Chr

BP

Effect Allele

Beta (S.E.)

Discovery p-value

Direction

Variance explained

Replication p-value (HCS)

Direction (HCS)

Gene

Feature

rs2873966

17

64211973

A

0.53 (0.10)

2.54E-07

+ +

0.025

0.068927

+

APOH

intronic

rs11655503

17

64027346

A

−0.97 (0.19)

4.24E-07

− −

0.028

0.010205

CEP112

intronic

rs8064837

17

64242703

G

−0.46 (0.09)

5.11E-07

− −

0.023

0.113782

N/A

N/A

rs1420791

17

63914750

G

−0.92 (0.19)

8.90E-07

− −

0.022

0.011073

CEP112

intronic

rs2010251

17

64203725

T

−0.61 (0.13)

1.26E-06

− −

0.022

0.03413

N/A

N/A

rs758767

17

64204591

A

−0.61 (0.13)

1.26E-06

− −

0.022

0.034137

N/A

N/A

rs7214750

17

63903119

T

−0.90 (0.19)

1.30E-06

− −

0.021

0.015964

CEP112

intronic

rs6431248

2

235202974

A

0.46 (0.10)

3.00E-06

+ +

0.021

0.722578

+

N/A

N/A

rs181247

17

56207731

A

0.58 (0.13)

4.88E-06

+ +

0.028

0.021183

+

N/A

N/A

rs12825437

12

5756980

A

−0.65 (0.14)

5.91E-06

− −

0.019

0.486807

+

TMEM16B

intronic

rs1519187

2

235201218

T

0.45 (0.10)

7.18E-06

+ +

0.02

0.876655

+

N/A

N/A

rs9562709

13

47727650

A

0.48 (0.11)

8.83E-06

+ +

0.018

0.488741

N/A

N/A

rs9591011

13

47728087

T

0.48 (0.11)

9.04E-06

+ +

0.017

0.488816

N/A

N/A

  1. Note: SNP annotation information from SNPnexus43; Variance explained = 2*p*q*beta2/Variance of ApoH, allele frequencies were estimated using Sydney MAS and ApoH variance from the discovery analysis; APOH, apolipoprotein H; CEP112, centrosomal protein 112kD; TMEM16B (ANO2), anoctamin 2.